BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 35419538)

  • 1. Clinical Validation of an Immune Quiescence Gene Expression Signature in Kidney Transplantation.
    Akalin E; Weir MR; Bunnapradist S; Brennan DC; Delos Santos R; Langone A; Djamali A; Xu H; Jin X; Dholakia S; Woodward RN; Bromberg JS
    Kidney360; 2021 Dec; 2(12):1998-2009. PubMed ID: 35419538
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Trifecta Study: Comparing Plasma Levels of Donor-derived Cell-Free DNA with the Molecular Phenotype of Kidney Transplant Biopsies.
    Halloran PF; Reeve J; Madill-Thomsen KS; Demko Z; Prewett A; Billings P;
    J Am Soc Nephrol; 2022 Feb; 33(2):387-400. PubMed ID: 35058354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between donor-derived cell-free DNA and tissue-based rejection-related transcripts in heart transplantation.
    Lee DH; Usmani A; Wu R; Wicks T; Noh CY; Burke R; Ravichandran V; Wolf-Doty T; Dumitru I; Oliveira GH; Berman P; Mackie B
    J Heart Lung Transplant; 2024 Jul; 43(7):1118-1125. PubMed ID: 38373559
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Variability in Donor-Derived Cell-Free DNA Scores to Predict Mortality in Heart Transplant Recipients - A Proof-of-Concept Study.
    Kamath M; Shekhtman G; Grogan T; Hickey MJ; Silacheva I; Shah KS; Shah KS; Hairapetian A; Gonzalez D; Godoy G; Reed EF; Elashoff D; Bondar G; Deng MC
    Front Immunol; 2022; 13():825108. PubMed ID: 35251005
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic Performance of Donor-Derived Plasma Cell-Free DNA Fraction for Antibody-Mediated Rejection in Post Renal Transplant Recipients: A Prospective Observational Study.
    Zhang H; Zheng C; Li X; Fu Q; Li J; Su Q; Zeng L; Liu Z; Wang J; Huang H; Xu B; Ye M; Liu L; Wang C
    Front Immunol; 2020; 11():342. PubMed ID: 32184785
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early clinical experience using donor-derived cell-free DNA to detect rejection in kidney transplant recipients.
    Huang E; Sethi S; Peng A; Najjar R; Mirocha J; Haas M; Vo A; Jordan SC
    Am J Transplant; 2019 Jun; 19(6):1663-1670. PubMed ID: 30725531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Donor-derived cell-free DNA as a biomarker for rejection after kidney transplantation: a systematic review and meta-analysis.
    Wijtvliet VPWM; Plaeke P; Abrams S; Hens N; Gielis EM; Hellemans R; Massart A; Hesselink DA; De Winter BY; Abramowicz D; Ledeganck KJ
    Transpl Int; 2020 Dec; 33(12):1626-1642. PubMed ID: 32981117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Donor-derived cell-free DNA (dd-cfDNA) for detection of allograft rejection in pediatric kidney transplants.
    Puliyanda DP; Swinford R; Pizzo H; Garrison J; De Golovine AM; Jordan SC
    Pediatr Transplant; 2021 Mar; 25(2):e13850. PubMed ID: 33217125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic value of donor-derived cell-free DNA to predict antibody-mediated rejection in donor-specific antibody-positive renal allograft recipients.
    Mayer KA; Doberer K; Tillgren A; Viard T; Haindl S; Krivanec S; Reindl-Schwaighofer R; Eder M; Eskandary F; Casas S; Wahrmann M; Regele H; Böhmig GA
    Transpl Int; 2021 Sep; 34(9):1689-1702. PubMed ID: 34448270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distinct Molecular Processes Mediate Donor-derived Cell-free DNA Release From Kidney Transplants in Different Disease States.
    Gauthier PT; Madill-Thomsen KS; Demko Z; Prewett A; Gauthier P; Halloran PF;
    Transplantation; 2024 Apr; 108(4):898-910. PubMed ID: 38150492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dynamic Response of Donor-Derived Cell-Free DNA Following Treatment of Acute Rejection in Kidney Allografts.
    Wolf-Doty TK; Mannon RB; Poggio ED; Hinojosa RJ; Hiller D; Bromberg JS; Brennan DC
    Kidney360; 2021 Apr; 2(4):729-736. PubMed ID: 35373051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High levels of dd-cfDNA identify patients with TCMR 1A and borderline allograft rejection at elevated risk of graft injury.
    Stites E; Kumar D; Olaitan O; John Swanson S; Leca N; Weir M; Bromberg J; Melancon J; Agha I; Fattah H; Alhamad T; Qazi Y; Wiseman A; Gupta G
    Am J Transplant; 2020 Sep; 20(9):2491-2498. PubMed ID: 32056331
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validation of a gene expression signature to measure immune quiescence in kidney transplant recipients in the CLIA setting.
    Cheung R; Xu H; Jin X; Tian W; Pinney K; Bu L; Stone S; Woodward RN; Agrawal N; Dholakia S; Phan RT
    Biomark Med; 2022 Jun; 16(8):647-661. PubMed ID: 35485169
    [No Abstract]   [Full Text] [Related]  

  • 14. Levels of donor-derived cell-free DNA and chemokines in BK polyomavirus-associated nephropathy.
    Mayer KA; Omic H; Weseslindtner L; Doberer K; Reindl-Schwaighofer R; Viard T; Tillgren A; Haindl S; Casas S; Eskandary F; Heinzel A; Kozakowski N; Kikić Ž; Böhmig GA; Eder M
    Clin Transplant; 2022 Nov; 36(11):e14785. PubMed ID: 35894263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Absolute quantification of donor-derived cell-free DNA as a marker of rejection and graft injury in kidney transplantation: Results from a prospective observational study.
    Oellerich M; Shipkova M; Asendorf T; Walson PD; Schauerte V; Mettenmeyer N; Kabakchiev M; Hasche G; Gröne HJ; Friede T; Wieland E; Schwenger V; Schütz E; Beck J
    Am J Transplant; 2019 Nov; 19(11):3087-3099. PubMed ID: 31062511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combining donor-derived cell-free DNA and donor specific antibody testing as non-invasive biomarkers for rejection in kidney transplantation.
    Obrișcă B; Butiu M; Sibulesky L; Bakthavatsalam R; Smith KD; Gimferrer I; Warner P; Ismail G; Leca N
    Sci Rep; 2022 Sep; 12(1):15061. PubMed ID: 36064740
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sex-specific patterns of donor-derived cell-free DNA in heart transplant rejection: An analysis from the Genomic Research Alliance for Transplantation (GRAfT).
    DeFilippis EM; Sweigart B; Khush KK; Shah P; Agbor-Enoh S; Valantine HA; Vest AR
    J Heart Lung Transplant; 2024 Jul; 43(7):1135-1141. PubMed ID: 38460620
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Donor-Derived Cell-Free DNA (dd-cfDNA) in Kidney Transplant Recipients With Indication Biopsy-Results of a Prospective Single-Center Trial.
    Benning L; Morath C; Fink A; Rudek M; Speer C; Kälble F; Nusshag C; Beimler J; Schwab C; Waldherr R; Zeier M; Süsal C; Tran TH
    Transpl Int; 2023; 36():11899. PubMed ID: 38020751
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Using Both Plasma and Urine Donor-Derived Cell-Free DNA to Identify Various Renal Allograft Injuries.
    Chen XT; Qiu J; Wu ZX; Zhang H; Chen T; Yang SC; Zhao GD; He Y; Shen X; Luo JQ; Huang Y; Wang CX; Chen LZ; Wu CL; Huang G
    Clin Chem; 2022 Jun; 68(6):814-825. PubMed ID: 35587713
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transcriptomic signatures of chronic active antibody-mediated rejection deciphered by RNA sequencing of human kidney allografts.
    Shah Y; Yang H; Mueller FB; Li C; Gul Rahim SE; Varma E; Salinas T; Dadhania DM; Salvatore SP; Seshan SV; Sharma VK; Elemento O; Suthanthiran M; Muthukumar T
    Kidney Int; 2024 Feb; 105(2):347-363. PubMed ID: 38040290
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.